News for BrainsWay Ltd. (BWAY)

Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

**media[651629]**

Brainsway (BRSYF) is set to be a Gold Sponsor at the Clinical TMS Society's 2025 Annual Meeting in San Diego, California, from June 12-14. The company plans to

Deep TMS Takes Center Stage with Compelling Research BURLINGTON, Mass. and JERUSALEM, June 10, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY)

BrainsWay is actively evaluating similar investments in other leading U.S. mental health providers to raise awareness and expand access to transformative care

BrainsWay (BWAY) invests $5 million for a minority stake in Stella MSO, LLC. Stella operates over 20 mental health clinics serving more than 30,000 patients

BrainsWay (BRSYF) has announced a strategic equity financing deal with Stella MSO, a management services organization that operates over 20 mental health clinic

Revenue: $11.5 million in Q1 2025, a 27% increase year-over-year.Deep TMS Systems Shipped: 81 systems in Q1 2025, a 42% increase compared to Q1 2024.Installed

May 13, 2025 / 12:30PM GMTOperator Good day, and welcome to the BrainsWay first quarter 2025 earnings conference call. (Operator instructions) Please -- please

BrainsWay Ltd. (NASDAQ:BWAY) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ETCompany ParticipantsBrian Ritchie – LifeSci Advisors LLCHadar Levy –...

BrainsWay Ltd (XTAE:BWAY) is set to release its Q1 2025 earnings on May 13, 2025. The consensus estimate for Q1 2025 revenue is $41.36 million, and the earnings

BrainsWay (BRSYF) is set to join the American Psychiatric Association Annual Meeting, scheduled from May 17 to May 21, 2025, in Los Angeles, California. The eve

Exhibit Booth Demonstrations and Participation in Expert Master Course Highlight BrainsWay's Expanding Role in Psychiatric Care BURLINGTON, Mass. and JERUSALE

BURLINGTON, Mass. and JERUSALEM, April 29, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (”œBrainsWay” or the ”œCompany”), a global lead

Revenue: $11.4 million in Q4 2024, a 27% year-over-year increase; $41 million for full year 2024, a 29% increase from 2023.Gross Margin: 75% in Q4 2024 and for

Mar 11, 2025 / 12:30PM GMTOperator Good day and welcome to the Brainsway fourth-quarter and full-year 2024 earnings conference call. (Operator Instructions) Ple

BrainsWay Ltd. (NASDAQ:BWAY) Q4 2024 Earnings Conference Call March 11, 2025 8:30 AM ETCompany ParticipantsBrian Ritchie - Investor Relations, LifeSci...

Achieved record quarterly sales of $11.4 million in Q4 2024, an increase of 27% compared with Q4 2023 Full year 2024 revenue increased nearly 30% YoY to $41 mi

BURLINGTON, Mass. and JERUSALEM, Israel, Feb. 24, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (”œBrainsWay” or the ”œCompany”), a glob